Retinoids' eects on cell growth and dierentiation are mediated by nuclear retinoid receptors, which are ligandactivated transcription enhancing factors. Because the expression of the retinoic acid receptor b (RARb) gene, which is located on chromosome 3p24, is diminished in premalignant and malignant tissues it has been proposed that it acts as a tumor suppressor. To test the hypothesis that RARb loss leads to retinoid resistance, we studied several karyotyped head and neck squamous carcinoma (HNSCC) cell lines (UMSCC-17A, -17B, -22A, -22B, and -38) with deletion of one chromosome 3p arm. RARb mRNA was neither detected nor induced by retinoic acid in these cells, whereas it was expressed and induced by retinoic acid in two other HNSCC cell lines (1483 and 183) without 3p deletion. Methylation of the RARb gene promoter was detected in the 17B and 22B cells that failed to express RARb but no methylation was found in 183A cells that did express RARb mRNA. Responsiveness of HNSCC cells to several retinoids in assays of growth inhibition and colony formation, was rank ordered as: 22B414834384183417B. Additionally, retinoid response elements were transactivated in 22B more eciently than in 17B cells. These results indicate that loss of RARb expression does not necessarily lead to loss of growth inhibition by retinoids or to a block of retinoid signaling. Oncogene (2001) 20, 6820 ± 6827.
Introduction
Retinoids have demonstrated some ecacy in animal models (Burge-Bottenbley and Shklar (1983) ; Schwartz et al. (1985) and in clinical trials with patients with oral premalignant lesions (Hong et al. (1986) . 13-cisRetinoic acid was also found to prevent the development of second primary tumors arising in patients who had been treated curatively for the ®rst primary HNSCC (Hong et al., 1990) .
Studies with cultured HNSCC cell lines have demonstrated that certain retinoids can inhibit cell proliferation and modulate squamous dierentiation in vitro (Hayashi et al. (2000) ; Lotan et al., 1991 Lotan et al., , 1994 Sun et al., 2000) and in vivo (Shalinsky et al., 1995 (Shalinsky et al., , 1997 . The eects of retinoids are thought to be mediated by nuclear retinoid receptors, which are ligand-activated transcription enhancing factors (Le et al., 2000; Wan et al., 1998 Wan et al., , 1999 Zou et al., 1994 Zou et al., , 1999 . Three retinoic acid receptors (RARa, RARb, and RARg), and three retinoid X receptors (RXRa, RXRb, and RXRg) have been identi®ed (Chambon 1996; Mangelsdorf and Evans 1995) . Each of them is encoded by a dierent gene: for example, RARa is located on chromosome band 17q21, RARb on 3p24, and RARg on chromosome 12 (Chambon 1996) . A retinoic acid response element (RARE) has been identi®ed in the RARb promoter region (de The et al., 1990; Homann et al., 1990) . The bRARE is transactivated by RAR-RXR heterodimers and the level of RARb transcript increases in response to ATRA due to the presence of this RARE (Chambon 1996; de The et al., 1990; Homann et al., 1990; Wan et al., 1999) . Although these RARs have a high homology in DNA binding and ligand binding domains, their dierent distribution and expression pattern during development suggest that they have dierent functions (Chambon 1996; Mangelsdorf and Evans 1995) .
Several groups have demonstrated that RARb expression is suppressed in certain malignant HNSCC cell lines and oral premalignant cells in vitro (Crowe et al., 1991; Hu et al., 1991; McGregor et al., 1997; Sun et al., 2000; Wan et al., 1999) . We found that 460% of surgical specimens from oral premalignant lesions (Lotan et al., 1995) and head and neck squamous cell carcinomas (HNSCCs) have lost the ability to express RARb. These and other studies (Berard et al., 1996; Gebert et al., 1991; Houle et al., 1993) have led to the suggestion that RARb can act as a tumor suppressor. Thus, the loss of its expression at early stages of carcinogenesis may enhance head and neck cancer development. The mechanisms underlying the loss of RARb expression are not fully elucidated. Deletions of the short arm of chromosome 3 were found in up to 60% of HNSCC tumors (Buchhagen et al., 1996; Latif et al., 1992; Maestro et al., 1993; Van Dyke et al., 1994) . Because RARb gene is located at 3p24 (Mattei et al., 1988) we wished to determine whether the loss of RARb expression in HNSCC is related to 3p deletion. In addition, we asked whether the loss of RARb expression leads to resistance to the growth inhibitory eect of all-trans-retinoic acid (ATRA), in HNSCC cell lines. For this purpose, we used human HNSCC cell lines with an established loss of one of the 3p arms.
Results

Differential expression of RARa and RARb in HNSCC cells
RARa mRNA was detected by RT ± PCR in all the cell lines examined. The tumor stage, original site and chromosome 3p status are summarized in Table 1 . In contrast, RARb mRNA was detected in the two cell lines (1483 and 183), which did not lose 3p arm, but not in the 5 cell lines (17A, -17B, -22A, -22B, and -38), which had suered 3p arm loss (Table 1, Figure 1 ). ATRA treatment (10 76 M, 24 h) increased RARb level in both 183 and 1483 cells but not in any of the other cell lines (Figure 1 ). These results indicate that the loss of one allele of 3p in these HNSCC cell lines resulted in suppression of RARb expression.
Southern blot analysis of RARb in HNSCC cells
No signi®cant dierences were noted in the pattern of DNA bands derived from the RARb gene after EcoR1 digestion and Southern blotting among the HNSCC cells with or without RARb expression. Further, the pattern was similar to that obtained with normal human genomic DNA (Figure 2) . No rearrangements or deletions were found by using a dierent restriction enzyme (BamHI) (data not shown). These results indicate that the cells have at least one apparently intact RARb gene.
RARb gene promoter is methylated in 17B and 22B HNSCC cell lines but not in 183A cells
Analysis of the methylation status of the RARb gene promoter using methylation-speci®c polymerase chain reaction (MS ± PCR) revealed that RARb was methylated in the UMSCC 17B and 22B cells but not in the 183A cells (Figure 3) . These results indicate that silencing of RARb expression from the residual allele in 17B and 22B can be explained by methylation of CpG island.
Differential sensitivity of the HNSCC cell lines to inhibition of monolayer growth by several retinoids is not related to the expression of RARb 76 M ATRA for 72 h. Total RNA was isolated and 1 mg of total RNA was used for reverse transcription with primers for RARa and RARb as described in Materials and methods. The RT ± PCR products were electrophoresed in 1.5% agarose gel and photographed under UV light. The lane on the left marked M represents molecular weight markers patterns of response as did 17B and 22B (data not shown).
Several receptor subtype selective retinoids (AM80, selective for RARa, TTNN, for RARb, CD666 for RARg, and 9-cisRA for RXRs), were also tested for their eects on HNSCC cell lines. The 22B cells were equally sensitive to all retinoids except TTNN (a RARb-selective retinoid), which was less potent. The 17B cells were poorly sensitive or insensitive to most of the retinoids tested ( Figure 4 ). These results indicate that 22B cells were most responsive to retinoids despite the 3p deletion and the loss of RARb expression. Conversely, the 183 cells, which exhibited the highest constitutive RARb expression, showed poor responsiveness to retinoids.
Differential suppression by ATRA of the ability of HNSCC cell lines to form colonies in Matrigel Basement Membrane Matrix
The ability of ATRA to inhibit colony formation was tested in Matrigel. The colony forming ability of untreated HNSCC cells was dierent for the ®ve cell lines tested with 17B and 1483 being the most ecient followed by 38 and 183 cells. The 22B cells were the least clonogenic ( Figure 5 ) although they formed larger colonies than the other cell lines (data not shown). The responsiveness to ATRA was also distinct for the dierent cell lines. 22B cells were found to be the most sensitive (63% inhibition) followed by 1483 (28%) and 38 cells (24%). In contrast, 17B and 183 cells were resistant ( Figure 4 ). These results clearly show that inhibition of colony formation by ATRA was far greater in 22B cells than in other cells despite the loss of RARb in the 22B cells.
Transactivation of RARE and RXRE by ATRA and 9cis RA is more effective in HNSCC 22B than in 17B cells Because both HNSCC 17B and 22B cell lines have lost RARb expression through 3p deletion yet one was responsive to retinoids (22B), whereas the other (17B) was resistant, we asked whether the cells dier in retinoid signaling. We used two reporter constructs containing RARE-or RXRE-CAT for transient transfection to evaluate transactivation by ATRA and 9-cisRA. The result indicated a dierent eect in 17B and 22B cells in induction of RARE reporter gene. ATRA and 9-cisRA were able to transactivate the RARE reporter in 22B by about 4 ± 5-fold (relative to DMSO control) but not in 17B cells (Figure 6a ). The RXRE reporter could not be activated by either ATRA or 9-cisRA in both 17B and 22B cells (Figure 6b ). However, co-transfection of RXRE-CAT and RXRa followed by treatment with 9-cis RA did show substantial activation of CAT in 22B but not in 17B cells (Figure 6c ). These results demonstrate that retinoid signaling is more eective in the 22B cells than in the 17B cells and this could explain the greater sensitivity of 22B cells to the growth inhibitory eects of retinoids compared with 17B cells.
Discussion
The most frequent autosomal abnormality in head and neck carcinoma are deletions in the chromosome arm 3p, which has been observed in about 60% of HNSCC patients. The common deletions include 3p14 ± 21, 3p21 ± 24, and 3p25 (Buchhagen et al., 1996; Latif et al., 1992; Maestro et al., 1993; Van Dyke et al., 1994) . Although RARb gene is located at 3p24 (Mattei et al., 1988) , its speci®c loss in HNSCC has not been demonstrated. However, recent studies with lung lesions have indicated a possible relationship between loss of heterozygosity (LOH) on chromosome 3p and a decrease in RARb expression (Picard et al., 1999) . LOH at 3p24 was observed in 41% of non-small cell lung cancer specimens and a marked decrease in the expression of RARb was detected in 63% of the tumors (Picard et al., 1999) .
LOH usually directs attention to the possibility that a tumor suppressor is located at the deleted site. Consequently, much attention has been given to various 3p loci as harboring candidate tumor suppressors. RARb has been proposed to act as a tumor suppressor (Berard et al., 1996; Crowe et al., 1991; Gebert et al., 1991; Houle et al., 1993; Hu et al., 1991; Lotan et al., 1995; McGregor et al., 1997; Xu et al., 1994) . Therefore, LOH at 3p24 or other mechanisms that suppress RARb expression may be associated with cancer development in the aerodigestive tract. One way through which loss of RARb expression could enhance carcinogenesis is by leading to a loss of response to retinoids. This contention is based on the idea that physiological retinoids may play a role in suppressing the development of certain cancers acting through nuclear receptors including RARb. The present study was designed speci®cally to address the question of whether loss of one chromosome 3p arm leads to suppression of RARb expression in HNSCC cells and whether such a loss also leads to resistance to growth inhibitory eects of retinoids. We examined RARb expression and retinoid responsiveness in several karyotyped cell lines with established 3p deletions. The results showed that these HNSCC cell lines (UMSCC-17A, -17B, -22A, -22B, and -38) failed to express RARb, despite the presence of one apparently normal allele as indicated by Southern blotting. Further, treatment with ATRA failed to induce RARb expression suggesting that the transcription from the normal 3p allele may be silenced. One mechanism for silencing is through methylation of the RARb promoter. Methylation of RARb has been reported recently in several cancer cell types (Bovenzi et al., 1999; Sirchia et al., 2000; Virmani et al., 2000; Widschwendter et al., 2000) , including the HNSCC cells UMSCC 17 and UMSCC22 used in the present study ( Figure 3 ) and this could be an explanation for the fact that many HNSCC cell lines show reduced or 76 M ATRA or DMSO (control). Cell colonies were allowed to develop in the Matrigel for 2 ± 3 weeks. The number of colonies was counted in ®ve high power ®elds under the microscope and the average+s.e. of three cultures is presented as bars Figure 6 Comparison of transactivation of RARE and RXRE by ATRA and 9-cisRA in UMSCC-17B and -22B HNSCC cells. The cells were co-transfected with reporter constructs RARE [(RARE) 3 -tk-CAT] (A), RXRE (pDSVCRBP-II-CAT) (B) or RXRE together with RXRa (C) and the RXRa expression construct pCMV-RXRa and b-galactosidase expression construct pCH110 as described in Materials and methods. After 4 h, the cells were treated with 10 76 M ATRA or 9-cisRA for 24 h. The cells were then lysed and the cytoplasmic extract was assayed for CAT activity and for b-galactosidase activity to normalize the CAT assay absent RARb expression (Crowe et al., 1991; Hu et al., 1991; McGregor et al., 1997; Sun et al., 2000; Youssef et al., 2001) .
The UMSCC-22B HNSCC cell line was found to be the most sensitive to retinoid-induced inhibition of growth in monolayer cultures and colony formation in Matrigel among the HNSCC cell lines examined. These cell lines included two cell lines (1483 and 183), which do not have a deletion of 3p and in which constitutively expressed RARb mRNA is detected by RT ± PCR even before treatment with ATRA. Thus, we concluded that chromosome 3p deletion, while associated with loss of RARb expression is not necessarily associated with loss of cell sensitivity to retinoids in the 22A and 22B cells. Possibly, RARa and RARg, which are expressed in these cells (Sun et al., 2000) can mediate some of the growth inhibitory eects of retinoids in the absence of RARb due to some redundant and overlapping eects. Indeed, RARg agonists were able to inhibit cell growth and treatment with RARg antagonist blocked the ability of the agonists to inhibit growth (Le et al., 2000) . However, in UMSCC-17A and -17B, 3p deletion and RARb loss were associated with retinoid resistance.
To ®nd out whether there were additional dierences between the 17B and 22B cells, we compared and contrasted the transactivation of RARE-and RXREdriven reporter gene by ATRA and 9-cisRA. We found that retinoid signaling in the 22B cells was higher than in 17B cells when RARE-CAT was transiently transfected or when RXRE-CAT was co-transfected with RXRa. Thus, it appears that transactivation of RARE-CAT by RARa-RXRa or RARg-RXRa and RXRa homodimers is higher in 22B than in 17B cells and this dierence may explain why the 22B cells are more sensitive to growth inhibitory eects of retinoids than 17B cells. Indeed, oral SCC cell clones constitutively overexpressing the dominant negative mutant RARb2 (R269Q), which can suppress RAR-RXR transcriptional transactivation activity, exhibited resistance to the growth inhibitory eects of ATRA (Le et al., 2000) . Conversely, overexpression of RARb in HNSCC cells that failed to express the endogenous gene resulted in growth arrest and apoptosis by 10 76 M 9cisRA (Hayashi et al., 2001) . The reason why ATRA failed to induce RARb in the 22B cells despite the ability of this retinoid to transactivate RARE-CAT may be that the endogenous RARb promoter is methylated (Youssef et al., 2001) , whereas the transiently transfected RARb2-RARE is not methylated. Indeed, MS ± PCR revealed that RARb promoter is methylated in the UMSCC17B and UMSCC22B cells.
In conclusion, loss of one allele of chromosome 3p and methylation of the remaining allele, occur early during head and neck carcinogenesis and can account at least in part, for the loss of RARb expression. However, this loss does not necessarily lead to the development of resistance to retinoids. Therefore, some patients with premalignant lesions that fail to express RARb may retain their ability to respond to retinoid intervention. It is also noteworthy that some of the HNSCC cell lines were apparently derived from tumors that developed without 3p allele loss and with continued RAR beta expression meaning that there is some way around retinoid growth suppression in patients even with this system intact.
Materials and methods
Cell lines and retinoids
The derivation of the human HNSCC cell lines UMSCC-17A, -17B, -22A, -22B, and -38 and MDA-183 and -1483 was described previously (Carey et al., 1989; Grenman et al., 1991; Krause et al., 1981; Sacks et al., 1988) . ATRA, 9cis RA, Am80, and TTNN were obtained from Dr W Bollag (Homann-La Roche, Inc. Basel, Switzerland) , and CD666 was obtained from Dr B Shroot (CIRD Galderma, Sophia Antipolis, France). The retinoids were dissolved in dimethylsulfoxide (DMSO) at a concentration of 10 72 M and stored brie¯y in the dark at 7208C under N 2 . Stock solutions were diluted to the desired ®nal concentration (10 79 M and 10 76 M) with growth medium.
Monolayer culture and growth inhibition assay
Cells were grown in monolayer culture in a 1 : 1 (v:v) mixture of Dulbecco's modi®ed Eagle's minimal essential medium (DMEM) and Ham's F12 medium containing 5% fetal bovine serum (FBS) at 378C in the humidi®ed atmosphere of 5% CO 2 :95% air. The cells were plated in 96-well tissue culture plates and treated with 10 79 M or 10 76 M ATRA, 9cisRA, Am80, TTNN, or CD666 for 3 days at which time they were refed with fresh medium without or with retinoids and cultured for an additional 2 days. Control cultures received the same amount of DMSO as treated cultures. Growth inhibition was determined on day 5 using crystal violet (CV) method as described by Kueng et al. (1989) . Brie¯y, after treatment, cells were ®xed with 5% glutaraldehyde and rinsed with distilled water, then dried. Cells were incubated with 1 : 1 (v:v) 200 mM 3-(cyclohexamino)-1-propanesulfonic acid, pH 9.5 and 0.2% CV at 258C for 30 min, then washed and dried. The ®xed and stained cells were solubilized with 10% glacial acetic acid and absorbance at 590 nm was determined using a plate reader. Growth inhibition was calculated from the equation: (1-At/Ac)6100 where Ac and At represent the absorbancies of control and treated cultures, respectively.
Colony formation in Matrigel
The cells were grown in Matrigel 1 basement membrane matrix (Collaborative Biomedical Products, Becton Dickinson Labware, Bedford, MA, USA) as described before . Brie¯y, 1610 5 cells were suspended in 0.2 ml of ice-cold Matrigel diluted 1 : 1 (vol:vol) with growth medium (Dulbecco's modi®ed Eagle's minimal essential medium and Ham's F12 medium supplemented 10% fetal bovine serum, FBS), placed on the top of 0.2 ml of semisolid 1% agarose in growth medium in each well of a 24-well cluster plate and then incubated at 378C for 2 weeks. To analyse the eect of ATRA, both bottom and top layers contained either 0.01% DMSO (vehicle, as a control) or 10 76 M ATRA. Half a milliliter of complete medium (with or without ATRA) was added on top of the Matrigel after 4 days and replaced every 4 days. After 2 weeks, colonies were counted under an inverted microscope at640 magni®cation in four microscopic ®elds. Per cent inhibition of colony formation was calculated using the equation: GI=(1-Nt/ Nc)6100; where Nt and Nc are the numbers of colonies in treated and control cultures, respectively.
Reverse-transcription polymerase chain reaction (RT ± PCR)
Total cellular RNA was puri®ed from retinoid-treated and control cells by the guanidinium thiocyanate method as described by Chirgwin et al. (1979) . The primers used in the RT ± PCR reaction were described by Ferrari et al. (1994) . RARb2 (329 bp): 5'-CATGTTTGACTGTATGGATG (5'-primer), 5'-AGCCCTTACATCCCTCACAG (3'-primer) (41), RARa (226 bp): 5'-ACCCCCTCTACCCCGCATCTACAAG (5'-primer), 5'-CATGCCCACTTCAAAGCACTTCTG (3'-primer). Reverse transcription of RNA from dierent cell lines was performed using 1 mg of total RNA and equal volumes of a stock of reverse transcription reaction mixture: 56 ®rst strand buer, 0.1 M DTT, 1 mM dNTP, 1 U/ml ribonuclease inhibitor, 2.5610 76 M random hexamer. and 2.5 U/ml Moloney murine leukemia virus reverse transcriptase (Gibco BRL). The reaction was carried out at 428C for 60 min. The PCR was performed on the cDNA product using dierent primers. The ampli®cation reaction took place in 10 mM Tris-HCl (pH 8.4), 5610
73 M MgCl 2 , 5 U/ml Amplitaq DNA polymerase, and 0.2 10 76 M primers. The reaction used a thermal cycler from Perkin-Elmer-Cetus with the following program: an initial 3 min incubation at 948C, followed by 35 ampli®cation cycles, 958C for 1 min, 608C for 1 min, and 728C for 1 min. The ®nal extension took place at 728C for 3 min. Then equal volumes of PCR product from each sample were subjected to electrophoresis on a 2% agarose gel stained with ethidium bromide and photographed.
DNA purification and Southern analysis
Genomic DNA was prepared from the HNSCC cell lines as previously described (Neel et al., 1981) . Normal human genomic DNA (purchased from Clontech). Samples containing 10 mg of DNA were digested with 100 units of the restriction enzymes EcoRI and BamHI and size-fractionated on 1% agarose gels. The DNA fragments were transferred onto nylon membranes by capillary transfer using 106 saline sodium citrate (SSC) overnight. Prehybridization and hybridization were performed at 658C using Amersham RapidHyb buer. The membranes were washed twice with 26SSC and 1% sodium dodecylsulfate at room temperature for 15 min and at 658C for 10 min. For autoradiography, X-ray ®lm was exposed for 48 h at 7808C with intensifying screens.
Methylation-specific PCR
The methylation status of RARb was determined by the MS ± PCR as described by Herman et al. (1996) . In brief, HNSCC 183A, 17B, and 22B, were harvested and used for the preparation of genomic DNA. After its isolation and puri®cation, 2 mg of genomic DNA were treated with sodium bisul®te for 16 h. After puri®cation, a 2 ml aliquot was used as a template for PCR using primers to dierentiate between methylated and unmethylated extracted DNA for RARb 5' promoter region as described by Cote et al. (1998) . The modi®ed primers for methylated sodium bisul®te DNA that provided 146-bp of the transcript were: 5'-TCGAGAACGC-GAGCGATTCG-3' (sense) in position 950 ± 969 and 5'-GACCAATCCAACCGAAACGA-3' (antisense) in position 1095 ± 1076, The annealing temperatures was 588C. Then equal volumes of PCR product from each sample were subjected to electrophoresis on a 2% agarose gel stained with ethidium bromide and photographed.
Transient transfections and reporter gene (CAT) transactivation assay
The following plasmids were used in transfection: The (RARE) 3 -tk-CAT (CAT=chloramphenicol acetyltransferase) construct contains a triple repeat of the RARE (733 to 759) from the RARb 2 promoter inserted into the SalI site of pBLCAT8+ upstream of the herpes simplex virus thymidine kinase promoter (tk) (Klein-Hitpass et al. (1988) . The pDSV-CRBPII-CAT (Mangelsdorf et al., 1991) construct consist of ®ve tandem repeats of a 35 bp sequence from the RXRE found in the promoter of the mouse CRBP-II gene (7605 to 7639) inserted immediately upstream of minimal SV40 promoter of pSV-CAT .
Transfection of 17B, 22B, and 1483 cells was carried out by the calcium phosphate-DNA precipitate method, essentially as described in Current Protocols in Molecular Biology (Ausubel et al., 1998) . The DNA precipitates were buered using BES-buered saline (50610 73 M N-,N-Bis [2-hydroxyethyl]-2-amino-ethanesulfonic acid, 280 mM NaCl, 1.5610 73 M Na 2 HPO 4 ). Cells were plated in 100-mm tissue culture dishes approximately 24 h prior to transfection at a density allowing subcon¯uence at the time of harvesting (10 6 cell/plate). One hour prior to DNA precipitation, cells were refed with fresh medium and transfected with either 5 mg (RARE) 3 -tk-CAT or 5 mg pDSV-CRBPII-CAT and 2 mg b-galactosidase expression construct pCH110. In addition, another tissue culture dish was transfected with 5 mg pDSV-CRBPII-CAT, 2 mg of the RXRa expression vector pCMVRXRa, and pCH110. The cells were exposed to the DNA for 4 ± 6 h in the presence of 3% CO 2 followed by a 2 min 10% glycerol shock. The plates were washed twice with PBS and refed with fresh medium supplemented with 5% FBS. Four hours later cells were treated with 10 76 M ATRA, 9cis-RA or 0.01% DMSO. Cytoplasmic lysates were obtained 24 h later by alternating freezing and thawing three times. A lysate volume corresponding to 5 U b-galactosidase activity was used to analyse CAT activity. The lysate was incubated for 1 h at 378C in a 150 ml ®nal reaction volume containing 0.25 M Tris-HCl, pH 7.5, 0.66610 73 M Acetyl-Coenzyme A, and 0.1610 76 Ci 14 C-labeled chloramphenicol (53 mCi/mmol, Amersham, Arlington Heights, IL, USA). The reaction was stopped by adding 1 ml ethyl acetate and vigorous mixing for 1 min, followed by vacuum drying of the ethyl acetate phase. The pellets were resuspended in 20 ml ethyl acetate and spotted on Chromagram silica gel thin-layer chromatography sheets (Kodak). Ascending chromatography in a ratio of chloroform:methanol (95 : 5) was followed by quantitation of acetylated and unacetylated chloramphenicol derivatives using a Betagen Betascope 603 blot analyser, and placement against Hyper-®lm for autoradiography at 7808C.
Abbreviations ATRA, All-trans-retinoic acid; 9-cisRA, 9-cis retinoic acid; RAR, retinoic acid receptor; RXR, retinoid X receptor; RARE, retinoic acid response element; RXRE, retinoid X response element; CVC, crystal violet; RT-PCR, reverse transcription polymerase chain reaction; CAT, chloramphenicol acetyl transferase; LOH, loss of heterozygosity.
